Explore our insights

Insights2019-11-21T11:54:02+01:00
907, 2020

INVESTIERE – “I’m bullish about the Swiss startup ecosystem”

July 9th, 2020|Featured, News|

Lucian Wagner has two decades of experience as a startup investor. Together with Jacqueline Ruedin Rüsch, he runs Privilège Ventures, a seed and early-stage venture capital firm active in Switzerland and Europe. In this interview, they share the story of how they came to invest in startups and what fascinates them about the Swiss startup ecosystem.

Swiss start-ups drive research around Covid-19

May 27th, 2020|Creoptix, Featured|

Swiss start-ups are very active in the quest for therapies against Covid-19. You can find several examples in our article from 5 May. According to the weekly updated view of the Covid-19 product pipeline creates by BIO’a Industry Analysis Team, Swiss companies run 25 different therapeutic programmes - more than companies from UK (22), Germany (21) or France (12).

2603, 2020

Utility of AVA – the Ava Bracelet to Diagnose and Monitor Symptoms Potentially Related to COVID-19

March 26th, 2020|Ava|

The Ava Bracelet is a wrist worn medical device* that tracks breathing rate, pulse rate, skin temperature, heart rate variability and perfusion. The most common symptoms of COVID-19 include fever (87.9% of cases), dry cough (67.7% of cases), and shortness of breath (18.6% of cases).

2401, 2020

The Invisible Danger: Hidden Polymers in Cosmetic Products

January 24th, 2020|Codecheck|

Many health and environmental issues are caused by our consumption. This is often due to a lack of awareness and information. At CodeCheck they are building a world where consumers can easily find products that are good for their health and for the future of our planet.

901, 2020

Diese App sagt bedenklichen Inhaltsstoffen den Kampf an

January 9th, 2020|Codecheck|

Was haben Acryllack und Weichspüler gemeinsam? Auf den ersten Blick nicht viel. Nimmt man jedoch die Inhaltsstoffe der Produkte genauer unter die Lupe, fällt auf, dass beide ein Biozid enthalten können, das ein hohes Allergiepotenzial aufweist und am Arbeitsplatz deshalb nur in geringer Konzentration erlaubt ist.

1312, 2019

Creoptix appoints Line Stigen Raquet as CEO

December 13th, 2019|Creoptix, Featured|

Creoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, today announced the appointment of Line Stigen Raquet as Chief Executive Officer with effect from beginning of January 2020. After seven years in the position, Matyas Vegh has decided to pursue new opportunities outside the company.

Ready to talk?

If you wish to get in touch just go ahead.

Let’s Talk